Trusted Press Release Distribution   Join | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Precision Business Insights
www.precisionbusinessinsights.com
Rajesh k
sales@precisionbusinessinsights.com
Precision Business Insights, Kemp House, 152 – 160 City Road,
EC1V 2NX

Bookmark and Share
Graft Versus Host Disease Treatment Market Size, Share, Trends, Growth 2013-2017, Forecast 2024
Global Graft Versus Host Disease Treatment Market report offers Market Size, Regional Share, Top Key Players, Latest trends, Growth, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024


Graft Versus Host Dise...
BriefingWire.com, 6/14/2018 - Market Dynamics: Graft Versus Host Disease Treatment Market

Rising count of the allogeneic hematopoietic stem cell transplant and increase in the prevalence of cancer patients are majorly driving the growth of graft versus host disease treatment market. The increasing bone marrow transplantations for various types of cancers is likely to drive the growth of the market. The growing R&D activities is helping in fastening up the drug development process which is expected to add fuel for the growth of the market. However, the higher investment in the initial stages of the clinical trials is likely to hamper the growth of the market. The strict government regulations for approvals is also hindering the growth of the graft versus host disease treatment market.

Free sample of this report is available upon request @

www.precisionbusinessinsights.com/market-reports/graft-versus-host-disease-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

Market Scope: Graft Versus Host Disease Treatment Market

Graft versus host disease treatment market is segmented based on the product type, disease type, and distribution channel

Based on the product type, the market is segmented into the following:

• Monoclonal Antibodies

• Tyrosine Kinase Inhibitors

• Thalidomide

• mTOR Inhibitors

• Others

Based on the disease type, the market is segmented into the following:

• Acute Graft vs. Host Disease (aGvHD)

• Chronic Graft vs. Host disease (cGvHD)

Based on the distribution channel, the market is segmented into the following:

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Free TOC of this report is available upon request @

www.precisionbusinessinsights.com/market-reports/graft-versus-host-disease-treatment-market/#ulp-c654SbFYO64MsOhu

Regional Analysis: Graft Versus Host Disease Treatment Market

Geographically, global graft versus host disease treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America graft versus host disease treatment market growing due to increase in the prevalence of cancer. The rising count of the bone transplantations is also considerably high in this region. The increasing healthcare expenditure and adoption of the modern treatment options are adding scope for the growth of the market in this region.

Competition Assessment: Graft Versus Host Disease Treatment Market

Some of the players in the global graft versus host disease treatment market include:

• Novartis AG (Switzerland)

• Merck & Co. (U.S)

• Soligenix, Inc. (U.S)

• Mesoblast Ltd (Australia)

• Sanofi (France)

• Neovii Biotech GmbH (Switzerland)

• Astellas Pharma Inc. (Japan)

• Mallinckrodt Pharmaceuticals (UK)

Notable Market Developments: Graft Versus Host Disease Treatment Market

? In November 2017, Merck & Co., Inc. received FDA Approval of PREVYMIS (letermovir) for Prevention of Cytomegalovirus (CMV) Infection and Disease in Adult Allogeneic Stem Cell Transplant Patients

Get access to full summary @

www.precisionbusinessinsights.com/market-reports/graft-versus-host-disease-treatment-market/

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Contact Person: Rajesh Babu

Role: Marketing Lead

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2013 Proserve Technology, Inc.